A Grothey Selected Research

A Grothey Research Topics

Disease

17	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 04/2001
13	Neoplasms (Cancer) 10/2022 - 04/2000
6	Colonic Neoplasms (Colon Cancer) 01/2020 - 05/2011
4	Breast Neoplasms (Breast Cancer) 04/2015 - 10/2000
2	Neutropenia 01/2020 - 11/2000
2	Carcinogenesis 04/2015 - 07/2001
2	Neoplasm Metastasis (Metastasis) 08/2005 - 04/2002
1	Liver Failure 10/2022
1	Adenocarcinoma 01/2021
1	Microsatellite Instability 01/2019
1	Turcot syndrome 01/2019
1	Carcinoma (Carcinomatosis) 04/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2012
1	Rectal Neoplasms (Rectal Cancer) 06/2012
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2010
1	Vomiting 09/2007
1	Nausea 09/2007
1	Stomach Neoplasms (Stomach Cancer) 04/2005
1	Hypersensitivity (Allergy) 04/2002
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2001
1	Inflammation (Inflammations) 07/2001
1	Thrombocytopenia (Thrombopenia) 11/2000
1	Infections 11/2000
1	Anemia 11/2000
1	Ovarian Neoplasms (Ovarian Cancer) 10/2000
1	Anaplastic Thyroid Carcinoma 05/2000

Drug/Important Bio-Agent (IBA)

6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 04/2002
4	Sodium Glutamate (Accent)IBA 01/2020 - 05/2011
3	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2021
3	encorafenibIBA 01/2022 - 01/2021
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 07/2001
3	Leucovorin (Folinic Acid)FDA Link 01/2020 - 07/2001
3	Proteins (Proteins, Gene)FDA Link 04/2015 - 10/2000
3	Cisplatin (Platino)FDA LinkGeneric 11/2000 - 04/2000
2	Bevacizumab (Avastin)FDA Link 10/2022 - 06/2014
2	binimetinibIBA 01/2022 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 05/2011 - 04/2002
2	fascinIBA 10/2000 - 10/2000
1	atezolizumabIBA 10/2022
1	B7-H1 AntigenIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	RamucirumabIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	regorafenibIBA 01/2016
1	Checkpoint Kinase 1IBA 04/2015
1	KSR-1 protein kinaseIBA 04/2015
1	Cell-Free Nucleic AcidsIBA 04/2015
1	AgarIBA 04/2015
1	Oncogene Proteins (Oncogene Protein)IBA 04/2015
1	thiamine triphosphorate (TTP)IBA 06/2014
1	Estrogen Receptor alphaIBA 07/2013
1	Tamoxifen FDA LinkGeneric 07/2013
1	Epidermal Growth Factor (EGF)IBA 06/2012
1	MagnesiumIBA 06/2012
1	CalciumIBA 06/2012
1	Cytotoxins (Cytolysins)IBA 05/2011
1	Tropisetron (Navoban)IBA 09/2007
1	Granisetron (Kytril)FDA LinkGeneric 09/2007
1	dolasetron (Anzemet)FDA Link 09/2007
1	Ondansetron (Zofran)FDA LinkGeneric 09/2007
1	Capecitabine (Xeloda)FDA Link 02/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2002
1	Interferon-alpha2bIBA 04/2002
1	SpherexIBA 04/2002
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2002
1	Protein Isoforms (Isoforms)IBA 07/2001
1	Butyric Acid (Butanoic Acid)IBA 07/2001
1	beta CateninIBA 07/2001
1	CarcinogensIBA 07/2001
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2001
1	TCF Transcription FactorsIBA 07/2001
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2001
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 07/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2000
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2000
1	Erythropoietin FDA Link 11/2000
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2000
1	Thrombopoietin (c-mpl Ligand)IBA 11/2000
1	Messenger RNA (mRNA)IBA 10/2000
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2000
1	Hormones (Hormone)IBA 10/2000
1	Progesterone FDA LinkGeneric 10/2000
1	Gemcitabine FDA Link 05/2000
1	Antineoplastic Agents (Antineoplastics)IBA 04/2000

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2018 - 11/2000
10	Therapeutics 10/2022 - 04/2002
2	Neoadjuvant Therapy 08/2005 - 07/2001
1	Immunotherapy 01/2021
1	Adjuvant Chemotherapy 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 04/2005
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2000